Bally's acquisition of Evoke is facing a regulatory challenge in Pennsylvania due to Evoke's existing B2B poker deal with Caesars, creating an overlap with Bally's current digital operations in the state. This issue could delay or complicate the finalization of the £243.1 million acquisition, impacting both companies involved.
Bally's Corporation's pending acquisition of Evoke is encountering a significant regulatory hurdle in Pennsylvania. Evoke's subsidiary, 888 Atlantic, has a B2B deal to provide services for Caesars' WSOP online platform in the state. Since Bally's already has digital operations in Pennsylvania, this overlap is causing issues for regulatory approval. This matters because it could delay or even jeopardize the £243.1 million acquisition, impacting Bally's growth strategy and Evoke's future. For traders, this presents a short-term risk for BALY stock due to uncertainty surrounding the deal's completion, while CZR is less directly affected but its partnership with Evoke is highlighted.